Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Conditions: End Stage Liver DIsease Interventions: Biological: umbilical cord-mesenchmal stem cells Sponsors: General Hospital of Shenyang Military Region Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa Interventions: Biological: GMP compliant-BM-MSC derived sEVs Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial
Conditions: Myelodysplastic Syndromes Interventions: Biological: Hematopoietic stem-cell transplantation Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
Conditions: Acute Myeloid Leukemia Interventions: Drug: Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;; Drug: Venetoclax (Venetoclax): 400mg on day 1 to day 7; oral administration;; Other: utologous stem cell transplantation (ASCT) /allogeneic hematopoietic stem cell transplantation (allo-HSCT). Sponsors: The First Affiliated Hospital with Nanjing Medical University; Huai ' an First People ' s Hospital; Yancheng First People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer
Conditions: Diabetic Foot Ulcer Interventions: Drug: Allogeneic mesenchymal stem cells (MSCs) / Placebo Sponsors: Supergenics Life Science Sdn. Bhd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis
Conditions: Multiple Sclerosis Interventions: Procedure: Autologous haemopoietic stem cell transplantation Sponsors: Tianjin Medical University General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration
Conditions: Melasma Interventions: Procedure: 1565 nm non-ablative fractional laser combined with normal saline; Procedure: microneedles combined with hUCMSC-Exos; Procedure: 1565 nm non-ablative fractional laser combined with hUCMSC-Exos; Procedure: PBASM combined with hUCMSC-Exos Sponsors: Fujian Medical University Union Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E
Conditions: Charcot-Marie-Tooth Disease, Type 1 Interventions: Biological: human Wharton ' s jelly-derived mesenchymal stem cells Sponsors: Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.
Conditions: Stem Cells Interventions: Dietary Supplement: NAD3 Sponsors: University of Memphis; Compound Solutions Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
Conditions: Multiple Sclerosis; Lower Urinary Tract Symptoms Interventions: Other: QoL monitoring Sponsors: University Hospital Ostrava Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Skin Rejuvenation Using Stem Cell Secretome
Conditions: Skin Rejuvenation Interventions: Biological: secretome Sponsors: COR clinic of Regenerative Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers
Conditions: CMV Sponsors: Grupo Espanol de trasplantes hematopoyeticos y terapia celular Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars
Conditions: Atrophic Scar Interventions: Biological: TRTP-101 Sponsors: CellinCells Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Conditions: Multiple Myeloma; Post-transplant MRD-guided Maintenance Therapy; Pre-transplant Purging Interventions: Drug: Elranatamab; Drug: Lenalidomide; Drug: Plerixafor; Drug: Melphalan; Drug: Busulfan; Drug: G-CSF; Procedure: Stem cell transplant Sponsors: M.D. Anderson Cancer Center; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Safety and Feasibility of TMLI as Conditioning Regimen in Allogeneic Hematopoietic Stem-cell Transplantation
Conditions: Acute Lymphoblastic Leukemia Interventions: Radiation: total marrow and total lymphoid irradiation Sponsors: Hospital Universitario Dr. Jose E. Gonzalez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
